Torray LLC Biomarin Pharmaceutical Inc Transaction History

Torray LLC

$678 Million
Q3 2024

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$74.43 - $92.22 $150,274 - $186,192	2,019 Added 13.61%	16,855 $1.39 Million
Q1 2024 May 10, 2024	SELL	$83.81 - $99.0 $1.23 Million - $1.45 Million	-14,680 Reduced 49.74%	14,836 $1.3 Million
Q1 2024 May 09, 2024	BUY	$83.81 - $99.0 $1.24 Million - $1.47 Million	14,848 Added 101.23%	29,516 $2.58 Million
Q4 2023 Feb 08, 2024	BUY	$76.22 - $98.51 $33,994 - $43,935	446 Added 3.14%	14,668 $1.41 Million
Q3 2023 Nov 08, 2023	BUY	$85.07 - $94.48 $275,711 - $306,209	3,241 Added 29.51%	14,222 $1.26 Million
Q2 2023 Jul 20, 2023	BUY	$86.68 - $100.3 $9,014 - $10,431	104 Added 0.96%	10,981 $951,000
Q1 2023 May 02, 2023	BUY	$87.74 - $117.27 $3,772 - $5,042	43 Added 0.4%	10,877 $1.06 Million
Q4 2022 Feb 08, 2023	SELL	$80.93 - $108.63 $37,713 - $50,621	-466 Reduced 4.12%	10,834 $1.12 Million
Q3 2022 Nov 04, 2022	SELL	$82.16 - $96.94 $22,101 - $26,076	-269 Reduced 2.33%	11,300 $958,000
Q2 2022 Aug 03, 2022	BUY	$71.48 - $86.85 $826,952 - $1 Million	11,569 New	11,569 $959,000
Q1 2022 May 03, 2022	SELL	$74.28 - $92.69 $908,964 - $1.13 Million	-12,237 Closed	0 $0
Q4 2021 Feb 04, 2022	SELL	$71.72 - $91.47 $298,785 - $381,064	-4,166 Reduced 25.4%	12,237 $1.08 Million
Q3 2021 Nov 02, 2021	BUY	$74.77 - $85.47 $15,253 - $17,435	204 Added 1.26%	16,403 $1.27 Million
Q2 2021 Aug 03, 2021	BUY	$75.51 - $84.79 $10,722 - $12,040	142 Added 0.88%	16,199 $1.35 Million
Q1 2021 May 03, 2021	SELL	$74.73 - $90.69 $3.74 Million - $4.54 Million	-50,070 Reduced 75.72%	16,057 $1.21 Million
Q4 2020 Feb 03, 2021	SELL	$72.61 - $90.2 $164,316 - $204,122	-2,263 Reduced 3.31%	66,127 $5.8 Million
Q3 2020 Nov 02, 2020	BUY	$71.87 - $131.03 $1.03 Million - $1.88 Million	14,320 Added 26.48%	68,390 $5.2 Million
Q2 2020 Aug 03, 2020	SELL	$79.55 - $124.22 $514,847 - $803,951	-6,472 Reduced 10.69%	54,070 $6.67 Million
Q1 2020 Apr 28, 2020	BUY	$71.37 - $96.85 $288,120 - $390,983	4,037 Added 7.14%	60,542 $5.12 Million
Q4 2019 Feb 11, 2020	SELL	$64.27 - $86.37 $9.35 Million - $12.6 Million	-145,450 Reduced 72.02%	56,505 $4.78 Million
Q3 2019 Nov 06, 2019	BUY	$67.4 - $85.11 $64,299 - $81,194	954 Added 0.47%	201,955 $13.6 Million
Q2 2019 Aug 08, 2019	SELL	$80.35 - $93.9 $1.53 Million - $1.79 Million	-19,086 Reduced 8.67%	201,001 $17.2 Million
Q1 2019 May 07, 2019	SELL	$84.2 - $98.62 $383,278 - $448,918	-4,552 Reduced 2.03%	220,087 $19.6 Million
Q4 2018 Feb 06, 2019	SELL	$80.14 - $106.07 $1.01 Million - $1.34 Million	-12,632 Reduced 5.32%	224,639 $19.1 Million
Q3 2018 Nov 02, 2018	SELL	$93.92 - $105.72 $415,502 - $467,705	-4,424 Reduced 1.83%	237,271 $23 Million
Q2 2018 Aug 14, 2018	SELL	$76.01 - $99.03 $630,959 - $822,048	-8,301 Reduced 3.32%	241,695 $22.8 Million
Q1 2018 May 14, 2018	BUY	$77.67 - $92.63 $170,640 - $203,508	2,197 Added 0.89%	249,996 $20.3 Million
Q4 2017 Feb 13, 2018	BUY	$80.76 - $95.13 $1.53 Million - $1.81 Million	19,003 Added 8.31%	247,799 $22.1 Million
Q3 2017 Nov 09, 2017	BUY	$80.6 - $94.95 $18.4 Million - $21.7 Million	228,796	228,796 $21.3 Million

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

Black Rock Inc. New York, NY

22.7M
Shares

$1.52 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19.3M
Shares

$1.28 Billion
0.02% of portfolio
Primecap Management CO Pasadena, CA

18.9M
Shares

$1.26 Billion
0.99% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$926 Million
0.59% of portfolio
Capital Research Global Investors Los Angeles, CA

10.5M
Shares

$699 Million
0.16% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Torray LLC, based on Form 13F filings with the SEC.

News

Stay updated on Torray LLC with notifications on news.

Account